For experimental confirmation of SE-mediated positive regulation of IRF4, CCND2, MYC, MYB, and PIK3C3 expression, we analyzed the expression levels of these proteins in BC-3 and BCBL-1 cells after treatment with the BET inhibitor JQ1. This evidence concerns the gene IRF4 and breast cancer.